当前位置: 首页 > 期刊 > 《中西医结合心血管病》 > 2018年第32期
编号:13267489
XB130在晚期食管癌患者肿瘤组织中的表达及对顺铂化疗敏感度性的影响(2)
http://www.100md.com 2018年11月15日 《中西医结合心血管病电子杂志》 2018年第32期
     参考文献

    [1]Xu J,Bai XH,Lodyga M,et al.XB130,a novel adaptor protein for signal transduction.J Biol Chem.2007,282(22):16401-12.

    [2]M.Uhlen,P.Oksvold,L.Fagerberg et al.Towards a knowledge-based human protein atlas.Nature Biotechnology,2010,28(12):1248-1250.

    [3]M.Lodyga,V.de Falco,X.-H. Bai et al.XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway.Oncogene,2009, 28(7):937-949.

    [4]Shiozaki A,Shen-Tu G,Bai X,et al.XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt. PLoS One.2012,7(8):e43646.

    [5]Shiozaki A,Lodyga M, Bai XH,et al.XB130,a novel adaptor protein,promotes thyroid tumor growth.Am J Pathol. 2011,178(1):

    391-401.

    [6]Zhang J,Jiang X,Zhang J.Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.World J Surg Oncol.2014 ,12:49.

    [7]Shi M,Huang W,Lin L, et al.Silencing of XB130 is associated with both the prognosis and chemosensitivity of gastric cancer.PLoS One.2012,7(8):e41660.

    本文編辑:李 豆, http://www.100md.com(李典芬 周太梅 杨前生 李剑鸿 阳大庆)
上一页1 2